With a commitment to innovation, AFT Pharmaceuticals develops, licenses and sells a wide range of products to help improve the health and wellbeing of people.
About AFT Pharmaceuticals.
Read More
Pharmaceuticals
with a difference
Browse latest news
We develop, license, and sell pharmaceutical products in Australasia and around the world. Check out our latest news.
Read More
Our range of innovative products
Learn more about our range of products.
Read More
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Read More
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
Read More
Our range of innovative products
Learn more about our range of products
Browse our products
Please select your region below to view products
Our Initiatives
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Our Initiatives
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
Maxigesic® Oral Liquid gets first regulatory approval
Maxigesic Oral Liquid – a non-opioid analgesic developed for children – achieves first approval in Europe to set up the first global launch and a pathway for further registrations and launches.
Read More
AFT at APP 2021
AFT Pharmaceuticals participate in the Australian Pharmacy Professional (APP) Conference and Trade Exhibition in May 2021.
Read More
AFT extends Maxigesic® IV license in South America
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has licensed Maxigesic IV into Colombia, Peru, Chile, Ecuador, Bolivia, and Uruguay, extending the medicine’s addressable market in Latin America and the Caribbean to 17 countries.
Read More